Department of Pathology, Faculty of Medicine in Pilsen, Charles University, E. Benese 13, 305 99, Pilsen, Czech Republic.
Bioptic Laboratory, Ltd, Pilsen, Czech Republic.
Virchows Arch. 2024 Jan;484(1):103-117. doi: 10.1007/s00428-023-03697-1. Epub 2023 Nov 14.
Branchioma is an uncommon benign neoplasm with an adult male predominance, typically occurring in the lower neck region. Different names have been used for this entity in the past (ectopic hamartomatous thymoma, branchial anlage mixed tumor, thymic anlage tumor, biphenotypic branchioma), but currently, the term branchioma has been widely accepted. Branchioma is composed of endodermal and mesodermal lineage derivatives, in particular epithelial islands, spindle cells, and mature adipose tissue without preexistent thymic tissue or evidence of thymic differentiation. Twenty-three branchiomas were evaluated morphologically. Eighteen cases with sufficient tissue were assessed by immunohistochemistry, next-generation sequencing (NGS) using the Illumina Oncology TS500 panel, and fluorescence in situ hybridization (FISH) using an RB1 dual-color probe. All cases showed a biphasic morphology of epithelial and spindle cells with intermingled fatty tissue. Carcinoma arising in branchioma was detected in three cases. The neoplastic cells showed strong AE1/3 immunolabeling (100%), while the spindle cells expressed CD34, p63, and SMA (100%); AR was detected in 40-100% of nuclei (mean, 47%) in 14 cases. Rb1 showed nuclear loss in ≥ 95% of neoplastic cells in 16 cases (89%), while two cases revealed retained expression in 10-20% of tumor cell nuclei. NGS revealed a variable spectrum of likely pathogenic variants (n = 5) or variants of unknown clinical significance (n = 6). Loss of Rb1 was detected by FISH in two cases. Recent developments support branchioma as a true neoplasm, most likely derived from the rudimental embryological structures of endoderm and mesoderm. Frequent Rb1 loss by immunohistochemistry and heterozygous deletion by FISH is a real pitfall and potential confusion with other Rb1-deficient head and neck neoplasms (i.e., spindle cell lipoma), especially in small biopsy specimens.
鳃裂瘤是一种不常见的良性肿瘤,男性多见,好发于颈下部。过去曾用不同的名称来描述这种实体(异位错构性胸腺瘤、鳃裂原混合瘤、胸腺原肿瘤、双相性鳃裂瘤),但目前已广泛接受鳃裂瘤这一术语。鳃裂瘤由内胚层和中胚层谱系衍生物组成,特别是上皮岛、梭形细胞和成熟脂肪组织,而无先前存在的胸腺组织或胸腺分化的证据。评估了 23 例鳃裂瘤。18 例有足够组织的病例进行了免疫组织化学评估、使用 Illumina Oncology TS500 面板进行下一代测序 (NGS) 以及使用 RB1 双色探针进行荧光原位杂交 (FISH)。所有病例均显示上皮和梭形细胞与混杂的脂肪组织的双相形态。检测到 3 例源自鳃裂瘤的癌。肿瘤细胞显示强烈的 AE1/3 免疫标记(100%),而梭形细胞表达 CD34、p63 和 SMA(100%);在 14 例中有 40-100%(平均 47%)的核中检测到 AR。在 16 例(89%)中有 16 例中 Rb1 显示核丢失,而在 2 例中有 10-20%的肿瘤细胞核保留表达。NGS 显示可能的致病性变异(n=5)或未知临床意义的变异(n=6)的可变谱。在 2 例中通过 FISH 检测到 Rb1 缺失。最近的研究进展支持鳃裂瘤是一种真正的肿瘤,最有可能源自内胚层和中胚层的原始胚胎结构。免疫组织化学中频繁的 Rb1 缺失和 FISH 中的杂合性缺失是一个真正的陷阱,可能与其他 Rb1 缺失的头颈部肿瘤(即梭形细胞脂肪瘤)混淆,尤其是在小活检标本中。